Heidelberg Pharma AG filed its Annual on Mar 24, 2023 for the period ending Nov 30, 2022. In this report its auditor, Deloitte & Touche LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
After market 02:15:34 pm | |||
2.97 EUR | 0.00% | 2.965 | -0.17% |
Apr. 25 | Heidelberg Pharma AG Reports Earnings Results for the First Quarter Ended February 29, 2024 | CI |
Apr. 23 | Transcript : Heidelberg Pharma AG - Special Call |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.59% | 150M | |
+9.09% | 114B | |
+11.47% | 104B | |
-13.01% | 22.41B | |
-1.05% | 22.28B | |
-5.29% | 19.07B | |
-38.29% | 18B | |
-3.24% | 17.89B | |
+8.07% | 14.28B | |
+34.91% | 12.55B |
- Stock Market
- Equities
- HPHA Stock
- News Heidelberg Pharma AG
- Heidelberg Pharma AG Auditor Raises 'Going Concern' Doubt